Table 1.
UGE findings | Number/Percent (n = 643) |
---|---|
Abnormal UGE | 486/75.5% |
Gastritis (Sydney classification) Mild Moderate Severe |
317/49.3% 277/87.4% 29/9.2% 11/3.4% |
Hiatus hernia Hiatal insufficiency or small hiatal hernia ≤ 3 cm Large hiatal hernia > 3 cm with/or without paraesophageal hernia |
168/26.1% 151/89.9% 17/10.1% |
H. Pylori infection | 98/15.2% |
Esophagitis (Los Angeles classification) Grade A Grade B Grade C Grade D |
78/12.1% 58/74.4% 11/14.1% 6/7.7% 3/3.8% |
GERD | 62/9.6% |
Erosions | 44/6.8% |
Polyps Gastric Duodenal Esophageal |
18/2.8% 15/83.3% 1/5.6% 2/11.1% |
Duodenitis | 11/1.7% |
Peptic Ulcer | 11/1.7% |
Metaplastic (chronic) atrophic gastritis | 11/1.7% |
Tumors Benign (submucosal gastric lipoma; esophageal squamous papilloma) Malignant (Neuroendocrine tumor—NET G3) |
2/0.3% 1/50% 1/50% |
Barrett’s esophagus (BE) | 2/0.3% |
Bezoar | 1/0.2% |
Glycogenic Acanthosis (esophagus) | 1/0.2% |